[HTML][HTML] PIPAC for gastrointestinal malignancies
SK Daniel, BJ Sun, B Lee - Journal of Clinical Medicine, 2023 - mdpi.com
The peritoneum is a common site of metastases for gastrointestinal tumors that predicts a
poor outcome. In addition to decreased survival, peritoneal metastases (PMs) can …
poor outcome. In addition to decreased survival, peritoneal metastases (PMs) can …
PIPAC Pharmacologic and Clinical Data
D Cortés‐Guiral, O Kranenburg… - Journal of Surgical …, 2024 - Wiley Online Library
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) emerged as an innovative
intraperitoneal chemotherapy delivery system to overcome the issue of limited efficacy of …
intraperitoneal chemotherapy delivery system to overcome the issue of limited efficacy of …
[HTML][HTML] Feasibility and safety of taxane-PIPAC in patients with peritoneal malignancies—a retrospective bi-institutional study
S Mehta, P Kammar, A Patel, G Goswami… - Indian Journal of …, 2023 - Springer
Taxanes have a favorable pharmacokinetic profile for intraperitoneal application. We report
our initial experience with taxane-PIPAC (pressurized intraperitoneal chemotherapy) for …
our initial experience with taxane-PIPAC (pressurized intraperitoneal chemotherapy) for …
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): ChemoAblation for Peritoneal Tumors
Abstract Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) is a novel way to
deliver chemotherapy for peritoneal metastases originating from various gastrointestinal and …
deliver chemotherapy for peritoneal metastases originating from various gastrointestinal and …